A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: Correlation between clinical responses and AUC pharmacokinetics

Carla Casulo, Julie M. Vose, William Y. Ho, Brad Kahl, Mark Brunvand, Andre Goy, Yvette Kasamon, Bruce Cheson, Jonathan W. Friedberg

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: Correlation between clinical responses and AUC pharmacokinetics'. Together they form a unique fingerprint.

Medicine & Life Sciences